D

DEKA Research & Development Corp.

Independent R&D lab developing medical devices

Engineering Project Manager

Full-TimeUpdated on 10/23/2026
No salary listed
Senior
Bachelor's
Manchester, NH, USA
In Person
Project & Program ManagementProject Management

About the job

Requirements
  • A bachelor's degree in an engineering discipline and at least five years leading medical device product development teams on challenging technical projects are required.
  • Experience with electromechanical products that include embedded software is required.
  • Direct experience leading projects from initial concept through design and release is required.
  • Experience successfully managing schedules, budgets, and project resources is required.
  • Strong project management and written and verbal communication skills are required.
  • A demonstrated track record of energy, drive, commitment, self-initiative, and perseverance is required.
Responsibilities
  • Lead a cross-functional technical team through design, verification and validation, clinical trials, and commercialization.
  • Translate high-level project goals into system requirements while working with internal and external stakeholders.
  • Provide technical and people leadership to project teams.
  • Drive delivery of goals while managing project schedules, costs, and resources.
  • Interface with customers and manage relationships to ensure clear communication and alignment of objectives.
  • Drive day-to-day project activity, remove roadblocks to technical and project challenges, manage resource conflicts, uphold high-performance standards, and meet commitments.
  • Create comprehensive project plans.
  • Work with upper management to drive project schedules and resolve roadblocks across DEKA projects.

About the company

D

DEKA Research & Development Corp.

View

DEKA Research & Development Corp. is a leading engineering R&D lab in Manchester, New Hampshire that develops a wide range of practical technologies and devices. It operates by interdisciplinary teams of engineers, machinists, designers, and technicians who take ambitious ideas and turn them into tangible products using advanced design and manufacturing methods. The company differentiates itself through its culture of hands-on experimentation, diverse project portfolio, and a track record of bringing to market or translating ideas into real-world applications. Its goal is to create technologies with a positive, lasting impact on people’s lives by solving meaningful problems.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Manchester, New Hampshire

Founded

1982

Get referred to DEKA Research & Development Corp.

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Diatech acquisition on October 7, 2025 deepened DEKA’s diabetes delivery stack.
  • Emergex collaboration keeps DEKA’s intradermal applicator active across 2026 biotech pipelines.
  • Revelio counted 872 employees in March 2026, and hiring stayed active.

What critics are saying

  • Sequel Med Tech drives twiist commercialization; any 2026 launch miss starves DEKA royalties.
  • Dean Kamen’s February 2026 Epstein scrutiny pressures recruiting, partnerships, and nonprofit ties.
  • DEKA’s revenue depends on a narrow medical-device portfolio; one regulatory failure hurts everything.

What makes DEKA Research & Development Corp. unique

  • Dean Kamen’s 1982 engineering bench produced LUKE, iBOT, and twiist.
  • DEKA owns core infusion and microneedle IP, not just outsourced design.
  • FDA cleared twiist in 2025, proving repeatable regulated-device execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Company News

Emergex Vaccines Holding Limited
Jan 16th, 2024
Emergex Announces R&D Collaboration with DEKA Research & Development Corp. for Assessment of Emergex's Immunotherapeutic Candidates with DEKA's Intradermal Therapeutic Applicator

- Emergex has entered into an agreement with DEKA Research & Development ('DEKA') to assess the compatibility of Emergex's T cell-priming set-point immunotherapeutic candidates with DEKA's Intradermal Therapeutic Applicator.

Business Wire
Oct 13th, 2022
Revolutionary And Affordable New Robotics System Makes Debut At 2022 First Global Challenge = A Win For Stem Equity

The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world. The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world